Segregation of effector mechanisms in a tumour-specific CD8+ T-cell clone correlates with CD30 expression

Scand J Immunol. 2001 Sep;54(3):314-20. doi: 10.1046/j.1365-3083.2001.00971.x.

Abstract

In this study we have analyzed CD30-antigen expression in three melanoma-directed cytotoxic T lymphocyte (CTL) clones with a T helper 0 (Th0)-like cytokine secretion profile (i.e. interleukin (IL)-4, IL-5, and interferon (IFN)-gamma). We show that all CTL clones expressed high levels of CD30 upon contact with the autologous tumour cells. One CTL clone, termed A2 with a monoclonal feature was selected for further analyses and found its CD30 expression dependent on the presence of IL-4. Functionally, a CD30-expressing A2 CTL was capable of producing higher amounts of IFN-gamma (up to 1.5-fold) and IL-4 (up to two-fold) than its CD30- counterpart. Furthermore, CD30-positive A2 CTL displayed an at least three-fold greater proliferative response to the tumour cell stimulation, contrasting with CD30- CTL. However, the antitumour cytotoxic activity of A2 CTL was not modulated by the CD30 expression. These results suggest that CD30 antigen can be inducible on a subset of tumour-directed CD8+ CTL, and that this subset of cells may have profound effector functions, such as cytokine secretion, proliferation, and cytotoxicity.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line, Transformed
  • Clone Cells
  • Cytokines / biosynthesis
  • Cytotoxicity Tests, Immunologic
  • Humans
  • Interferon-gamma / biosynthesis
  • Interleukin-4 / biosynthesis
  • Interleukin-4 / pharmacology
  • Interleukin-4 / physiology
  • K562 Cells
  • Ki-1 Antigen / biosynthesis*
  • Lymphocyte Activation
  • Melanoma / immunology*
  • Phenotype
  • T-Lymphocytes, Cytotoxic / immunology*
  • Tumor Cells, Cultured

Substances

  • Cytokines
  • Ki-1 Antigen
  • Interleukin-4
  • Interferon-gamma